FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Furosemide Injection
Status: Currently in Shortage
»Date first posted: 04/07/2020
»Therapeutic Categories: Cardiovascular

Expand all

Accord Healthcare Inc. (New 03/27/2023)

Company Contact Information:
866-941-7875

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
10 mg/ml (SDV) USP; 20 mg/2 ml; 25 pk [2 ml] Vial (NDC 16729-500-08)	Unavailable	Inventory on hold pending further assessment.	Other
10 mg/ml (SDV) USP; 40 mg/4 ml; 10 pk [4 ml] Vial (NDC 16729-501-43)	Unavailable	Inventory on hold pending further assessment.	Other
10 mg/ml (SDV) USP; 100 mg/10 ml; 10 pk [10 ml] Vial (NDC 16729-502-43)	Unavailable	Inventory on hold pending further assessment.	Other

Athenex Pharmaceutical Division, LLC (Athenex) (Reverified 03/24/2023)

Company Contact Information:
855-273-0154

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
20 mg/2mL vial (NDC 70860-302-41 and 70860-302-02)	Available
40 mg/4mL vial (NDC 70860-302-42 and 70860-302-04)	Available
100 mg/10mL vial (NDC 70860-302-43 and 70860-302-10)	Available

Avet Pharmaceuticals Inc (Revised 10/31/2022)

Company Contact Information:
855-228-9470

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
20 mg/mL (NDC 23155-473-41)	Available
40 mg/4mL (NDC 23155-473-42)	Available
100 mg/10mL (NDC 23155-473-44)	Available

Baxter Healthcare (Reverified 03/29/2023)

Company Contact Information:
888-229-0001

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Furosemide Injection, USP, 10 mg/mL - 10 mL Single Dose Glass Vial (25 x 10 mL) (NDC 36000-284-25)	Available
Furosemide Injection, USP, 10 mg/mL - 2 mL Single Dose Glass Vial (25 x 2 mL)(NDC 36000-282-25)	Available
Furosemide Injection, USP, 10 mg/mL - 4 mL Single Dose Glass Vial (25 x 4 mL)(NDC 36000-283-25)	Available

Eugia Pharma Specialties LTD. (formerly Aurobindo) (Reverified 03/17/2023)

Company Contact Information:
888-238-7880

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
20 mg/2 mL single-dose vial (NDC 55150-322-25)	Currently on backorder - next shipment TBD		Delay in shipping of the drug
40 mg/4 mL single-dose vial (NDC 55150-323-25)	Currently on backorder, next shipment TBD		Delay in shipping of the drug
100 mg/10 mL single-dose vial (NDC 55150-324-25)	Currently on backorder, next shipment TBD		Delay in shipping of the drug

Fresenius Kabi USA, LLC (Revised 03/31/2023)

Company Contact Information:
888-386-1300

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
20 mg per 2 mL (10 mg per mL), Amber, single dose vial (NDC 63323-280-02)	Available	Check wholesalers for inventory.	Demand increase for the drug
40 mg per 4 mL (10 mg per mL), Amber, single dose vial (NDC 63323-280-04)	Backordered. Next release April 2023.		Demand increase for the drug
100 mg per 10 mL (10 mg per mL), Amber, single dose vial (NDC 63323-280-10)	Available	Check wholesalers for inventory.	Demand increase for the drug

Gland Pharma Limited (Reverified 07/01/2022)

Company Contact Information:
866-625-1618

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
2 mL in 1 vial, 25 vials/carton (NDC 25021-311-02)	Available		Demand increase for the drug
4 mL in 1 vial, 25 vials/carton (NDC 25021-311-04)	Available		Demand increase for the drug
10 mL in 1 vial, 25 vials/carton (NDC 25021-311-10)	Available		Demand increase for the drug

Hospira, Inc., a Pfizer company (Revised 03/31/2023)

Company Contact Information:
844-646-4398

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
20 mg/2 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 0409-6102-02)	Available		Other
40 mg/4 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 0409-6102-04)	Limited Supply Available. Next Delivery: April 2023; Estimated Recovery: June 2023	Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay	Other
100 mg/10 mL (10 mg/mL): Single Dose Glass Fliptop Vial (NDC 0409-6102-10)	Limited Supply Available. Next Delivery: May 2023; Estimated Recovery: June 2023	Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay	Other
20 mg/2 mL (10 mg/mL); Single Dose Glass Fliptop Vial NovaPlus (NDC 0409-6102-25)	Available		Other
40 mg/4 mL (10 mg/mL); Single Dose Glass Fliptop Vial NovaPlus (NDC 0409-6102-26)	Available		Other
100 mg/10 mL (10 mg/mL): Single Dose Glass Fliptop Vial NovaPlus (NDC 0409-6102-27)	Next Delivery: April 2023; Estimated Recovery: June 2023	Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay	Other

Meitheal Pharmaceuticals, Inc. (Reverified 02/13/2023)

Company Contact Information:
844-824-8426

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
20 mg per 2 mL (NDC 71288-205-03)	Available
40 mg per 4 mL (NDC 71288-203-05)	Available
100 mg per 10 mL (NDC 71288-203-11)	Available

Sagent Pharmaceuticals (Reverified 03/22/2023)

Company Contact Information:
866-625-1618

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
20 mg/2 mL single-dose vial (NDC 25021-311-02)	Available.
40 mg/4 mL single-dose vial (NDC25021-311-04)	Available.
100 mg/10 mL single-dose vial (NDC 25021-311-10)	Available